BackgroundIn recent years, magnetic resonance imaging (MRI) has become important in brain tumor diagnosis. Using this modality, physicians can locate specific pathologies by analyzing differences in tissue character presented in different types of MR images.This paper uses an algorithm integrating fuzzy-c-mean (FCM) and region growing techniques for automated tumor image segmentation from patients with menigioma. Only non-contrasted T1 and T2 -weighted MR images are included in the analysis. The study's aims are to correctly locate tumors in the images, and to detect those situated in the midline position of the brain.MethodsThe study used non-contrasted T1- and T2-weighted MR images from 29 patients with menigioma. After FCM clustering, 32 groups of images from each patient group were put through the region-growing procedure for pixels aggregation. Later, using knowledge-based information, the system selected tumor-containing images from these groups and merged them into one tumor image. An alternative semi-supervised method was added at this stage for comparison with the automatic method. Finally, the tumor image was optimized by a morphology operator. Results from automatic segmentation were compared to the "ground truth" (GT) on a pixel level. Overall data were then evaluated using a quantified system.ResultsThe quantified parameters, including the "percent match" (PM) and "correlation ratio" (CR), suggested a high match between GT and the present study's system, as well as a fair level of correspondence. The results were compatible with those from other related studies. The system successfully detected all of the tumors situated at the midline of brain.Six cases failed in the automatic group. One also failed in the semi-supervised alternative. The remaining five cases presented noticeable edema inside the brain. In the 23 successful cases, the PM and CR values in the two groups were highly related.ConclusionsResults indicated that, even when using only two sets of non-contrasted MR images, the system is a reliable and efficient method of brain-tumor detection. With further development the system demonstrates high potential for practical clinical use.
Midline shift (MLS) of the brain is an important feature that can be measured using various imaging modalities including X-ray, ultrasound, computed tomography, and magnetic resonance imaging. Shift of midline intracranial structures helps diagnosing intracranial lesions, especially traumatic brain injury, stroke, brain tumor, and abscess. Being a sign of increased intracranial pressure, MLS is also an indicator of reduced brain perfusion caused by an intracranial mass or mass effect. We review studies that used the MLS to predict outcomes of patients with intracranial mass. In some studies, the MLS was also correlated to clinical features. Automated MLS measurement algorithms have significant potentials for assisting human experts in evaluating brain images. In symmetry-based algorithms, the deformed midline is detected and its distance from the ideal midline taken as the MLS. In landmark-based ones, MLS was measured following identification of specific anatomical landmarks. To validate these algorithms, measurements using these algorithms were compared to MLS measurements made by human experts. In addition to measuring the MLS on a given imaging study, there were newer applications of MLS that included comparing multiple MLS measurement before and after treatment and developing additional features to indicate mass effect. Suggestions for future research are provided.
Stereotactic radiosurgery (SRS), which delivers high doses of irradiation in a single or few shots to small targets, has been a standard of care for brain metastases. While very effective, SRS currently requires manually intensive delineation of tumors. In this work, we present a deep learning approach for automated detection and segmentation of brain metastases using multimodal imaging and ensemble neural networks. In order to address small and multiple brain metastases, we further propose a volume-aware Dice loss which optimizes model performance using the information of lesion size. This work surpasses current benchmark levels and demonstrates a reliable AI-assisted system for SRS treatment planning for multiple brain metastases.
HSRT can turn some giant AVMs manageable for single-dose radiosurgery. Six-Gray fractions were better than 5-Gy and routine embolization seemed unhelpful. There was no increase in bleeding risk with this approach. Future studies with longer follow-up are necessary to confirm our observation.
Efficient identification of patient, intervention, comparison, and outcome (PICO) components in medical articles is helpful in evidence-based medicine. The purpose of this study is to clarify whether first sentences of these components are good enough to train naive Bayes classifiers for sentence-level PICO element detection. We extracted 19,854 structured abstracts of randomized controlled trials with any P/I/O label from PubMed for naive Bayes classifiers training. Performances of classifiers trained by first sentences of each section (CF) and those trained by all sentences (CA) were compared using all sentences by ten-fold cross-validation. The results measured by recall, precision, and F-measures show that there are no significant differences in performance between CF and CA for detection of O-element (F-measure=0.731±0.009 vs. 0.738±0.010, p=0.123). However, CA perform better for I-elements, in terms of recall (0.752±0.012 vs. 0.620±0.007, p<0.001) and F-measures (0.728±0.006 vs. 0.662±0.007, p<0.001). For P-elements, CF have higher precision (0.714±0.009 vs. 0.665±0.010, p<0.001), but lower recall (0.766±0.013 vs. 0.811±0.012, p<0.001). CF are not always better than CA in sentence-level PICO element detection. Their performance varies in detecting different elements.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.